Whitepaper
Life sciences industry outlook for 2025 and beyond
Baker Tilly’s outlook e-book on what lies ahead for industry leaders
Feb. 13, 2025 · Authored by Darren R. Jones, Michelle Kupka, Michelle Abel, Timothy J. Nugent, Mark Scallon, Samantha Sutherland, Mario Prohasky, John A. Rogula, Keith Needham
As the life sciences industry faces ongoing change, staying ahead of evolving trends is more crucial than ever. Economic, political and technological forces are reshaping the landscape, requiring organizations to adapt to new challenges. From regulatory changes and shifts to digital transformation, these developments will have a significant impact on compliance, risk management and stakeholder engagement.
Looking ahead to 2025, the life sciences industry outlook highlights the importance of emerging trends which is key for organizations to drive growth and mitigate risks. Leveraging data and technology will play an increasingly influential role in decision-making, allowing organizations to build stronger relationships and ensure long-term success. The evolving landscape presents both opportunities and obstacles, and those who can adapt will be better positioned for the future.
Key topics for consideration:
- Capital markets: Economic and policy shifts are shaping investment strategies and access to capital.
- Drug pricing: Regulatory changes and legal challenges are influencing pricing strategies and market access.
- Healthcare professional (HCP) engagement: Organizations are refining engagement strategies to align with evolving compliance expectations.
- Enterprise risk management: Proactive approaches to risk and compliance are essential for navigating ongoing uncertainty.
- Evidence generation: Demonstrating product value and meeting regulatory expectations are driven by strategic, data-driven approaches.
Get ahead of the curve and prepare for what’s next. Download our complimentary e-book to learn more and explore actionable insights and strategies to navigate the year ahead.
